Abbisko Cayman Ltd

HKSE:02256 (China)  
HK$ 4.32 (-0.92%) Dec 23
At Loss
P/B:
1.18
Market Cap:
HK$ 2.70B ($ 347.76M)
Enterprise V:
HK$ 494.08M ($ 63.61M)
Volume:
276.00K
Avg Vol (2M):
4.33M
Trade In:
Volume:
276.00K
At Loss
Avg Vol (2M):
4.33M

Business Description

Description
Abbisko Cayman Ltd is an investment holding company that operates through its subsidiaries which is a clinical-stage biopharmaceutical company dedicated to the discovery and development of innovative and differentiated small molecule oncology therapies. The company has only one business segment which is the development of innovative medicines.
Name Current Vs Industry Vs History
Cash-To-Debt 68.98
Equity-to-Asset 0.95
Debt-to-Equity 0.01
Debt-to-EBITDA 0.38
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 8.94
Distress
Grey
Safe
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 34.95
9-Day RSI 41.29
14-Day RSI 46.1
6-1 Month Momentum % 33.97
12-1 Month Momentum % 19.43

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 21.75
Quick Ratio 21.75
Cash Ratio 21.09

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio 2.7
Shareholder Yield % 2.61

Financials

HKSE:02256's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Abbisko Cayman Ltd Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil HK$) 535.336
EPS (TTM) (HK$) -0.039
Beta 1.16
Volatility % 57.27
14-Day RSI 46.1
14-Day ATR (HK$) 0.235513
20-Day SMA (HK$) 4.5985
12-1 Month Momentum % 19.43
52-Week Range (HK$) 2.05 - 5.39
Shares Outstanding (Mil) 625.26

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Abbisko Cayman Ltd Filings

Filing Date Document Date Form
No Filing Data

Abbisko Cayman Ltd Stock Events

Financials Calendars
Event Date Price(HK$)
No Event Data

Abbisko Cayman Ltd Frequently Asked Questions

What is Abbisko Cayman Ltd(HKSE:02256)'s stock price today?
The current price of HKSE:02256 is HK$4.32. The 52 week high of HKSE:02256 is HK$5.39 and 52 week low is HK$2.05.
When is next earnings date of Abbisko Cayman Ltd(HKSE:02256)?
The next earnings date of Abbisko Cayman Ltd(HKSE:02256) is .
Does Abbisko Cayman Ltd(HKSE:02256) pay dividends? If so, how much?
Abbisko Cayman Ltd(HKSE:02256) does not pay dividend.

Press Release

Subject Date
No Press Release